• Differential effects of completed and incomplete pregnancies on the risk of Alzheimer disease 

      Jang H., Bae J.B., Dardiotis E., Scarmeas N., Sachdev P.S., Lipnicki D.M., Han J.W., Kim T.H., Kwak K.P., Kim B.J., Kim S.G., Kim J.L., Moon S.W., Park J.H., Ryu S.-H., Youn J.C., Lee D.Y., Lee D.W., Lee S.B., Lee J.J., Jhoo J.H., Yannakoulia M., Kosmidis M.H., Hadjigeorgiou G.M., Sakka P., Kim K.W. (2018)
      Objective To investigate the effects of completed pregnancy with childbirth and incomplete pregnancy without childbirth on the late-life cognition and the risk of Alzheimer disease (AD) in women. Methods Using the pooled ...
    • International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 

      Jacobs B.C., van den Berg B., Verboon C., Chavada G., Cornblath D.R., Gorson K.C., Harbo T., Hartung H.-P., Hughes R.A.C., Kusunoki S., van Doorn P.A., Willison H.J., the IGOS Consortium, Jacobs B.C., Hughes R.A.C., Cornblath D.R., Gorson K.C., Hartung H.P., Kusunoki S., van Doorn P.A., Willison H.J., van Woerkom M., van den Berg B., Verboon C., Roodbol J., Jacobs B.C., Reisin R.C., Reddel S.W., Islam Z., Islam B., Mohammad Q.D., van den Bergh P., Feasby T.E., Wang Y.Z., Harbo T., Péréon Y., Hartung H.P., Lehmann H.C., Dardiotis E., Nobile-Orazio E., Kusunoki S., Shahrizaila N., Jacobs B.C., van den Berg B., Verboon C., Bateman K., Illa I., Querol L.A., Hsieh S.T., Willison H.J., Chavada G., Davidson A., Gorson K.C., Addington J.M., Ajroud-Driss S., Andersen H., Antonini G., Attarian S., Badrising U., Barroso F.A., Benedetti L., Beronio A., Bianco M., Binda D., Briani C., Bürmann J., Bella I.R., Bertorini T.E., Bhavaraju-Sanka R., Brannagan T.H., Busby M., Butterworth S., Campagnolo M., Casasnovas C., Cavaletti G., Chao C.S., Chen S., Chetty S., Claeys K.G., Cohen J.A., Conti M.E., Cosgrove J.S., Dalakas M.C., Dimachkie M.M., Dillmann U., Domínguez González C., Doppler K., Dornonville de la Cour C., Echaniz-Laguna A., Eftimov F., Faber C.G., Fazio R., Fokke C., Fujioka T., Fulgenzi E.A., Galassi G., Garcia T., Garnero M., Garssen M.P.J., Gijsbers C.J., Gilchrist J.M., Gilhuis H.J., Goldstein J.M., Goyal N., Granit V., Grapperon A., Gutiérrez Gutiérrez G., Gutmann L., Hadden R.D.M., Holbech J.V., Holt J.K.L., Homedes Pedret C., Htut M., Jellema K., Jericó Pascual I., Kaida K., Karafiath S., Katzberg H.D., Kiers L., Kieseier B.C., Kimpinski K., Kleyweg R.P., Kokubun N., Kolb N.A., Kuitwaard K., Kuwabara S., Kwan J.Y., Ladha S.S., Landschoff Lassen L., Lawson V., Ledingham D., Léon Cejas L., Luciano C.A., Lucy S.T., Lunn M.P.T., Magot A., Manji H., Marchesoni C., Marfia G.A.M., Márquez Infante C., Martinez Hernandez E., Mataluni G., Mattiazi M., McDermott C.J., Meekins G.D., Miller J., Monges M.S., Montero M.C.J., Morís de la Tassa G., Nascimbene C., Neumann C., Nowak R.J., Orizaola Balaguer P., Osei-Bonsu M., Pan E.B.L., Pardo Fernandez J., Pasnoor M., Pulley M.T., Rajabally Y.A., Rinaldi S., Ritter C., Roberts R.C., Rojas-Marcos I., Rudnicki S.A., Sachs G.M., Samijn J.P.A., Santoro L., Saperstein D.S., Savransky A., Schneider H., Schenone A., Sedano Tous M.J., Sekiguchi Y., Sheikh K.A., Silvestri N.J., Sindrup S.H., Sommer C.L., Stein B., Stino A.M., Spyropoulos A., Srinivasan J., Suzuki H., Taylor S.W., Tankisi H., Tigner D., Twydell P.T., Valzania F., van Damme P., van der Kooi A.J., van Dijk G.W., van der Ree T., van Koningsveld R., Varrato J.D., Vermeij F.H., Verschuuren J.J.G.M., Visser L.H., Vytopil M.V., Waheed W., Wilken M., Wilkerson C., Wirtz P.W., Yamagishi Y., Yiu E.M., Zhou L., Zivkovic S. (2017)
      Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which ...
    • Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study 

      Elbaz, A.; Nelson, L. M.; Payami, H.; Ioannidis, J. P.; Fiske, B. K.; Annesi, G.; Carmine Belin, A.; Factor, S. A.; Ferrarese, C.; Hadjigeorgiou, G. M.; Higgins, D. S.; Kawakami, H.; Krüger, R.; Marder, K. S.; Mayeux, R. P.; Mellick, G. D.; Nutt, J. G.; Ritz, B.; Samii, A.; Tanner, C. M.; Van Broeckhoven, C.; Van Den Eeden, S. K.; Wirdefeldt, K.; Zabetian, C. P.; Dehem, M.; Montimurro, J. S.; Southwick, A.; Myers, R. M.; Trikalinos, T. A. (2006)
      Background: A genome-wide association study identified 13 single-nucleotide polymorphisms (SNPs) significantly associated with Parkinson's disease. Small-scale replication studies were largely non-confirmatory, but a ...
    • A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease 

      Krüger, R.; Sharma, M.; Riess, O.; Gasser, T.; Van Broeckhoven, C.; Theuns, J.; Aasly, J.; Annesi, G.; Bentivoglio, A. R.; Brice, A.; Djarmati, A.; Elbaz, A.; Farrer, M.; Ferrarese, C.; Gibson, J. M.; Hadjigeorgiou, G. M.; Hattori, N.; Ioannidis, J. P. A.; Jasinska-Myga, B.; Klein, C.; Lambert, J. C.; Lesage, S.; Lin, J. J.; Lynch, T.; Mellick, G. D.; de Nigris, F.; Opala, G.; Prigione, A.; Quattrone, A.; Ross, O. A.; Satake, W.; Silburn, P. A.; Tan, E. K.; Toda, T.; Tomiyama, H.; Wirdefeldt, K.; Wszolek, Z.; Xiromerisiou, G.; Maraganore, D. M. (2011)
      High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common ...
    • A revised international prognostic score system for Waldenström’s macroglobulinemia 

      Kastritis E., Morel P., Duhamel A., Gavriatopoulou M., Kyrtsonis M.C., Durot E., Symeonidis A., Laribi K., Hatjiharissi E., Ysebaert L., Vassou A., Giannakoulas N., Merlini G., Repousis P., Varettoni M., Michalis E., Hivert B., Michail M., Katodritou E., Terpos E., Leblond V., Dimopoulos M.A. (2019)
      A staging system was developed a decade ago for patients with Waldenström’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised staging system could better capture prognosis of WM patients in ...
    • Simplified criteria for the diagnosis of autoimmune hepatitis 

      Hennes, E. M.; Zeniya, M.; Czaja, A. J.; Parés, A.; Dalekos, G. N.; Krawitt, E. L.; Bittencourt, P. L.; Porta, G.; Boberg, K. M.; Hofer, H.; Bianchi, F. B.; Shibata, M.; Schramm, C.; De Torres, B. E.; Galle, P. R.; McFarlane, I.; Dienes, H. P.; Lohse, A. W. (2008)
      Diagnosis of autoimmune hepatitis (AIH) may be challenging. However, early diagnosis is important because immunosuppression is life-saving. Diagnostic criteria of the International Autoimmune Hepatitis Group (IAIHG) were ...